chr12-51807281-G-A
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The NM_001330260.2(SCN8A):c.5795G>A(p.Arg1932Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000164 in 1,461,694 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1932P) has been classified as Likely benign.
Frequency
Consequence
NM_001330260.2 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 13Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- cognitive impairment with or without cerebellar ataxiaInheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- seizures, benign familial infantile, 5Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- benign familial infantile epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile convulsions and choreoathetosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- myoclonus, familial, 2Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SCN8A | NM_001330260.2 | c.5795G>A | p.Arg1932Gln | missense_variant | Exon 27 of 27 | ENST00000627620.5 | NP_001317189.1 | |
| SCN8A | NM_014191.4 | c.5795G>A | p.Arg1932Gln | missense_variant | Exon 27 of 27 | ENST00000354534.11 | NP_055006.1 | |
| SCN8A | NM_001177984.3 | c.5672G>A | p.Arg1891Gln | missense_variant | Exon 26 of 26 | NP_001171455.1 | ||
| SCN8A | NM_001369788.1 | c.5672G>A | p.Arg1891Gln | missense_variant | Exon 26 of 26 | NP_001356717.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCN8A | ENST00000354534.11 | c.5795G>A | p.Arg1932Gln | missense_variant | Exon 27 of 27 | 1 | NM_014191.4 | ENSP00000346534.4 | ||
| SCN8A | ENST00000627620.5 | c.5795G>A | p.Arg1932Gln | missense_variant | Exon 27 of 27 | 5 | NM_001330260.2 | ENSP00000487583.2 | ||
| SCN8A | ENST00000599343.5 | c.5828G>A | p.Arg1943Gln | missense_variant | Exon 26 of 26 | 5 | ENSP00000476447.3 | |||
| SCN8A | ENST00000355133.7 | c.5672G>A | p.Arg1891Gln | missense_variant | Exon 25 of 25 | 1 | ENSP00000347255.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000803 AC: 2AN: 249066 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461694Hom.: 1 Cov.: 33 AF XY: 0.0000138 AC XY: 10AN XY: 727128 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy Uncertain:1
This variant is present in population databases (rs371766742, gnomAD 0.007%). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1932 of the SCN8A protein (p.Arg1932Gln). This variant has not been reported in the literature in individuals affected with SCN8A-related conditions. ClinVar contains an entry for this variant (Variation ID: 1516886). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SCN8A protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at